These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33836493)

  • 1. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Skeith L; Le Gal G; Rodger MA
    Thromb Res; 2021 Jun; 202():134-138. PubMed ID: 33836493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of hormone-associated venous thromboembolism: a patient management approach.
    Ueng J; Douketis JD
    Hematol Oncol Clin North Am; 2010 Aug; 24(4):683-94, vii-viii. PubMed ID: 20659653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.
    Beyer-Westendorf J; Bauersachs R; Hach-Wunderle V; Zotz RB; Rott H
    Vasa; 2018 Oct; 47(6):441-450. PubMed ID: 30008249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism associated with pregnancy and hormonal therapy.
    Jacobsen AF; Sandset PM
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in women: a specific reproductive health risk.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Oedingen C; Scholz S; Razum O
    Thromb Res; 2018 May; 165():68-78. PubMed ID: 29573722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.
    Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M
    Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
    Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
    JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
    Waselenko JK; Nace MC; Alving B
    Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.